Investigation of Small Bowel Abnormalities in HIV-Infected Patients Using Capsule Endoscopy
Table 4
Association between clinical factors and villous atrophy.
Villous atrophy (+)
Villous atrophy (−)
value
Number
13
11
Age, year
43.8 ± 11.1
44.9 ± 8.8
0.80
Duration after initial diagnosis, median (range), year
4.0 (0–9.0)
4.0 (0–20.0)
0.35
Clinical symptoms
Abdominal pain
1 (8%)
0 (0%)
>0.99
Diarrhea
10 (77%)
4 (36%)
0.10
Serum albumin value, g/dL
4.4 ± 0.5
4.4 ± 0.6
0.89
Hemoglobin value, g/dL
13.8 ± 1.9
14.1 ± 1.5
0.34
CRP, mg/dL
0.2 ± 0.3
0.2 ± 0.3
0.65
HAART therapy
10 (77%)
8 (73%)
0.81
Peripheral blood CD4
5 (38%)
2 (18%)
0.28
HAART: highly active antienteroviral therapy; values were analyzed using Fisher’s exact test or Student’s t-test for age and the Mann-Whitney U test for follow-up duration.
